2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值

2021-08-21 国外神经内科相关专家小组(统称) Journal of Neurology

帕金森病(PD)是一种神经退行性疾病,特征是运动和非运动功能障碍相结合。吞咽困难是帕金森病的一种常见症状,本文主要针对帕金森病吞咽困难的筛查、诊断和预后的相关内容提供共识建议。

中文标题:

2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值

英文标题:

A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value

发布日期:

2021-08-21

简要介绍:

帕金森病(PD)是一种神经退行性疾病,特征是运动和非运动功能障碍相结合。吞咽困难是帕金森病的一种常见症状,本文主要针对帕金森病吞咽困难的筛查、诊断和预后的相关内容提供共识建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值.pdf)] GetToolGuiderByIdResponse(projectId=1, id=479ab1c002202914, title=2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值, enTitle=A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value, guiderFrom=Journal of Neurology, authorId=0, author=, summary=帕金森病(PD)是一种神经退行性疾病,特征是运动和非运动功能障碍相结合。吞咽困难是帕金森病的一种常见症状,本文主要针对帕金森病吞咽困难的筛查、诊断和预后的相关内容提供共识建议。, cover=https://img.medsci.cn/20211012/1634018630624_5579292.jpg, journalId=0, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sat Aug 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">帕金森病(PD)是一种神经退行性疾病,特征是运动和非运动功能障碍相结合。吞咽困难是帕金森病的一种常见症状,本文主要针对帕金森病吞咽困难的筛查、诊断和预后的相关内容提供共识建议。</span></p>, tagList=[TagDto(tagId=337, tagName=帕金森病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=337, guiderKeyword=帕金森病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3156, appHits=136, showAppHits=0, pcHits=1122, showPcHits=3020, likes=0, shares=17, comments=7, approvalStatus=1, publishedTime=Tue Oct 12 14:13:50 CST 2021, publishedTimeString=2021-08-21, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Tue Oct 12 14:06:37 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Thu Jan 04 14:43:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值.pdf)])
2021 多国共识:帕金森病吞咽困难的筛查、诊断和预后价值.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1184507, encodeId=73f8118450e32, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b471301520, createdName=taozhonghai-1971, createdTime=Sat Jan 15 09:20:55 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065859, encodeId=26b310658591e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065292, encodeId=7b071065292c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 30 15:28:48 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064638, encodeId=d09b1064638ee, content=非常棒?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e65540768, createdName=ms5000000654000328, createdTime=Thu Oct 28 10:45:13 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060010, encodeId=3848106001002, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 13 07:02:21 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
    2022-01-15 taozhonghai-1971

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1184507, encodeId=73f8118450e32, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b471301520, createdName=taozhonghai-1971, createdTime=Sat Jan 15 09:20:55 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065859, encodeId=26b310658591e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065292, encodeId=7b071065292c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 30 15:28:48 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064638, encodeId=d09b1064638ee, content=非常棒?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e65540768, createdName=ms5000000654000328, createdTime=Thu Oct 28 10:45:13 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060010, encodeId=3848106001002, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 13 07:02:21 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
    2021-11-01 124151c2m00暂无昵称

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1184507, encodeId=73f8118450e32, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b471301520, createdName=taozhonghai-1971, createdTime=Sat Jan 15 09:20:55 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065859, encodeId=26b310658591e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065292, encodeId=7b071065292c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 30 15:28:48 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064638, encodeId=d09b1064638ee, content=非常棒?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e65540768, createdName=ms5000000654000328, createdTime=Thu Oct 28 10:45:13 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060010, encodeId=3848106001002, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 13 07:02:21 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
    2021-10-30 148aef65m02暂无昵称

    学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1184507, encodeId=73f8118450e32, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b471301520, createdName=taozhonghai-1971, createdTime=Sat Jan 15 09:20:55 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065859, encodeId=26b310658591e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065292, encodeId=7b071065292c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 30 15:28:48 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064638, encodeId=d09b1064638ee, content=非常棒?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e65540768, createdName=ms5000000654000328, createdTime=Thu Oct 28 10:45:13 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060010, encodeId=3848106001002, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 13 07:02:21 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
    2021-10-28 ms5000000654000328

    非常棒?

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1184507, encodeId=73f8118450e32, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4b471301520, createdName=taozhonghai-1971, createdTime=Sat Jan 15 09:20:55 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065859, encodeId=26b310658591e, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6efb2459695, createdName=124151c2m00暂无昵称, createdTime=Mon Nov 01 17:26:54 CST 2021, time=2021-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065292, encodeId=7b071065292c2, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/04/22/aca158650c3fcc25df7af56b9f1f338f.jpg, createdBy=75455322219, createdName=148aef65m02暂无昵称, createdTime=Sat Oct 30 15:28:48 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1064638, encodeId=d09b1064638ee, content=非常棒?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26e65540768, createdName=ms5000000654000328, createdTime=Thu Oct 28 10:45:13 CST 2021, time=2021-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060010, encodeId=3848106001002, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Wed Oct 13 07:02:21 CST 2021, time=2021-10-13, status=1, ipAttribution=)]
    2021-10-13 微探

    学习学习

    0

拓展阅读

2015 ICS指南:帕金森病和其他步态障碍性疾病膀胱功能障碍的管理

国际尿控协会(ICS,International Continence Society) · 2015-03-25

中国帕金森病的诊断标准(2016版)

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-11

2016 中国帕金森病及运动障碍疾病临床大数据库建设专家共识

中华医学会神经病学分会帕金森病及运动障碍学组 · 2016-07-30

帕金森病脑深部电刺激疗法术后程控中国专家共识

中华医学会神经外科学分会 · 2016-12-30

2016中国帕金森病诊断标准解读

暂未更新 · 2017-04-06

帕金森病康复中国专家共识

中华医学会神经病学分会神经康复学组 · 2018-04-15